| Views | |
|---|---|
| Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant | 62 |
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant | 4 | 0 | 2 | 0 | 2 | 1 | 1 |
| Views | |
|---|---|
| Severina_Molecular_20.pdf | 45 |
| Views | |
|---|---|
| United States | 24 |
| Germany | 5 |
| Canada | 3 |
| Vietnam | 3 |
| EU | 1 |
| South Korea | 1 |
| Portugal | 1 |
| Russia | 1 |
| Views | |
|---|---|
| Mountain View | 6 |
| Houston | 5 |
| Fairfield | 3 |
| Hanoi | 3 |
| Ottawa | 3 |
| Baltimore | 2 |
| Palo Alto | 2 |
| White Plains | 2 |
| Beirã | 1 |
| Coburg | 1 |